Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AVTX
MLAB
Add up to 3 more stocks
AVTX
Avalo Therapeutics, Inc.
-6.24%
$13.69-0.91Delayed quote: Oct 6, 2026, 12:10 PM EDT
Market Cap
$719.59M
52W Range
$12.51 - $24.27
MLAB
Mesa Laboratories, Inc.
-2.92%
$138.08-4.15Delayed quote: Oct 6, 2026, 12:05 PM EDT
Market Cap
$772.68M
52W Range
$66.56 - $144.70
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 164.38 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 12.10 |
| P/B Ratio | 1.60 | 4.09 |
| P/S Ratio | 12196.38 | 3.09 |
| P/FCF Ratio | N/A | 14.61 |
| EV/EBITDA | N/A | 18.56 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 66.0% |
| Operating Margin | -123601.7% | 9.0% |
| Net Margin | -170055.9% | 1.9% |
| ROE | -22.4% | 2.5% |
| ROA | -20.4% | 1.1% |
| ROIC | -19.4% | 3.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 19.31 | 2.07 |
| Quick Ratio | 19.31 | 1.52 |
| Debt/Equity | 0.00 | 0.54 |
| Interest Coverage | N/A | 1.73 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 0.5% |
| Payout Ratio | N/A | 76.2% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.